Atlas Trials

A Phase 1 Study to Evaluate the Safety, Reactogenicity and Immunogenicity of YKYY025 Injection

Clinical trial NCT07694557 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07694557
Sponsor
Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Respiratory Syncytial Virus (RSV)
Start date
2026-07-15
Primary completion
2028-07-01
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.